Project

Back to overview

Immunogenicity and safety of tetanus booster vaccine and hepatitis A vaccine in patients with rheumatoid arthritis, spondylarthritis and vasculitis - a cohort study in 6 Swiss rheumatology centres and 4 travel clinics

English title Immunogenicity and safety of tetanus booster vaccine and hepatitis A vaccine in patients with rheumatoid arthritis, spondylarthritis and vasculitis - a cohort study in 6 Swiss rheumatology centres and 4 travel clinics
Applicant Hatz Christoph
Number 143480
Funding scheme Project funding (Div. I-III)
Research institution Institut für Epidemiologie, Biostatistik und Prävention Universität Zürich
Institution of higher education University of Zurich - ZH
Main discipline Infectious Diseases
Start/End 01.01.2014 - 30.11.2017
Approved amount 481'753.00
Show all

All Disciplines (2)

Discipline
Infectious Diseases
Internal Medicine

Keywords (5)

Vaccination; Immunocompromised; Rheumatic; Immunogenicity; Safety

Responsible applicant and co-applicants

Employees

Publications

Publication
Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals
Burkhard J., Ciurea A., Gabay C., Hasler P., Müller R., Niedrig M., Fehr J., Villiger P., Visser L.G., de Visser A.W., Walker U.A., Hatz C., Bühler S. (2020), Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals, in Vaccine.
Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases—a prospective multi-centre cohort study
Bühler Silja, Jaeger Veronika Katharina, Adler Sabine, Bannert Bettina, Brümmerhoff Carolin, Ciurea Adrian, Distler Oliver, Franz Juliane, Gabay Cem, Hagenbuch Niels, Herzog Christian, Hasler Paul, Kling Kerstin, Kyburz Diego, Müller Rüdiger, Nissen Michael John, Siegrist Claire-Anne, Villiger Peter Matthias, Walker Ulrich A., Hatz Christoph (2019), Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases—a prospective multi-centre cohort study, in Rheumatology, 58(9), 1585-1596.

Collaboration

Group / person Country
Types of collaboration
Rheumatology Outpatient department, Inselspital, University Hospital Bern Switzerland (Europe)
- Research Infrastructure
Rheumatology Outpatient Department, Cantonal Hospital St. Gallen Switzerland (Europe)
- Research Infrastructure
Bernhard Nocht Institute for Tropical Medicine Germany (Europe)
- in-depth/constructive exchanges on approaches, methods or results
- Publication
- Research Infrastructure
Department of Pathology and Immunology Université de Genève Centre Medical Universitaire Switzerland (Europe)
- Research Infrastructure
Department of Rheumatology, Universitätsspital Basel Switzerland (Europe)
- Research Infrastructure
Scientific Institute of Public Health in Brussels, Belgium at the National Reference Centre for Meas Belgium (Europe)
- Research Infrastructure
Rheumatology Outpatient Department, Hôpitaux Universitaires de Genève Switzerland (Europe)
- Research Infrastructure
Rheumatology Outpatient Department, Cantonal Hospital Aarau Switzerland (Europe)
- Research Infrastructure
Swiss TPH, Basel Switzerland (Europe)
- Research Infrastructure
Rheumatology Outpatient department, University Hospital, University of Zurich. Switzerland (Europe)
- Research Infrastructure

Scientific events

Active participation

Title Type of contribution Title of article or contribution Date Place Persons involved
BNI Lunch Seminar Individual talk Live vaccinations in immunosuppressed individuals 08.01.2020 Hamburg, Germany Bühler Silja;
Conference on Tropical Medicine and Global Health 2019 Talk given at a conference Long-term immunogenicity after yellow fever vaccination in immunosuppressed individuals and controls 05.04.2019 München, Germany Neumayr Andreas; Bühler Silja;
Probevorlesung zur Erlangung der Habilitation Individual talk Reisen unter immunsuppression 22.11.2017 Universität Zürich, Switzerland Bühler Silja;
Reisemedizin Weiterbildung am USB Individual talk Wie sollten wir den immunsupprimierten Patienten impfen? 27.06.2017 Basel, USB, Switzerland Walker Ulrich; Bühler Silja; Hatz Christoph;
9th European Congress on Tropical Medicine and International Health Poster Immunogenicity and safety of hepa33s A and tetanus booster vaccination in patients with rheumatic diseases – interim results on tetanus vaccination 06.10.2015 Basel, Switzerland Adler Sabine; Hatz Christoph; Ciurea Adrian; Neumayr Andreas; Bühler Silja; Held Leonhard; Walker Ulrich;
Fortbildungsreihe Innere Medizin Individual talk Aktuelle schweizweite prospektive Kohortenstudie – Immunogenität und Sicherheit der Tetanus und Hepatitis A Impfung bei Patienten mit rheumatischen Erkrankungen im Vergleich zu gesunden Kontrollpersonen 17.02.2015 Aarau, KSA, Switzerland Bühler Silja; Hatz Christoph;


Knowledge transfer events

Active participation

Title Type of contribution Date Place Persons involved
Sanofi - Erstellung eines Rheumaatlas Talk 13.12.2019 Frankfurt, Germany Bühler Silja;
Reisemedizin update / Vacademy 2019 des Swiss TPH Talk 12.12.2019 Basel, Switzerland Bühler Silja; Hatz Christoph; Neumayr Andreas;
6. DGVS Seminar Gastroenterologische Infektionen Talk 02.11.2019 Hamburg, Germany Bühler Silja;
Tropenkurs am Bernhard-Nocht-Institut Talk 22.05.2019 Hamburg, Germany Bühler Silja;
Sanofi Inhouse Weiterbildung Talk 21.02.2019 Berlin, Germany Bühler Silja;
Reisemedizin Weiterbildung 2017 Talk 27.06.2017 USB Basel, Switzerland Bühler Silja; Hatz Christoph;
Fortbildungsreihe Innere Medizin Talk 17.02.2015 Kantonsspital Aarau, Switzerland Bühler Silja; Hatz Christoph;


Communication with the public

Communication Title Media Place Year
Media relations: print media, online media Tetanus und Diphtherie Auffrischimpfung auch für Rheumapatienten Pharmazeutische Zeitung - Die zeitschrift der Deutschen Apotheken International 2019

-